Terms: = Breast cancer AND PALB2, ENSG00000083093, 79728 AND Clinical Outcome
3 results:
1. Clinicopathological Features and outcomes in Individuals with breast cancer and ATM, CHEK2, or palb2 Mutations.
Bergstrom C; Pence C; Berg J; Partain N; Sadeghi N; Mauer C; Pirzadeh-Miller S; Gao A; Li H; Unni N; Syed S
Ann Surg Oncol; 2021 Jun; 28(6):3383-3393. PubMed ID: 32996020
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and palb2 genes in 2769 unselected breast cancer patients in China.
Deng M; Chen HH; Zhu X; Luo M; Zhang K; Xu CJ; Hu KM; Cheng P; Zhou JJ; Zheng S; Chen YD
Int J Cancer; 2019 Sep; 145(6):1517-1528. PubMed ID: 30720863
[TBL] [Abstract] [Full Text] [Related]
3. Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer.
Hunter FW; Hsu HL; Su J; Pullen SM; Wilson WR; Wang J
Mol Cancer Ther; 2014 Nov; 13(11):2501-14. PubMed ID: 25193512
[TBL] [Abstract] [Full Text] [Related]
